An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies. Xiang J, Devenport JM, Carter AJ, Staser KW, et al. Leukemia 2023;37:2448-2456.

Read + Share

Amedeo Smart

Independent Medical Education

Xiang J, Devenport JM, Carter AJ, Staser KW, et al. An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies. Leukemia 2023;37:2448-2456.
PMID: 37798328